Carrillo-Esper R, Carrillo-Córdova JR, Carrillo-Córdova LD

Language: Spanish
References: 36
Page: 301-308
PDF size: 106.31 Kb.

ABSTRACT

Background: Consistent data about sepsis in Mexico are lacking. The objective of this epidemiological study is to better define the incidence, characteristics and outcome of sepsis in Mexican intensive care units (ICUs). Methods: This is a multicenter transverse study performed in both private and public ICUs. Demographic data, comorbid diseases and clinical and laboratory data were collected prospectively. Results: A total of 135 ICUs from 24 states of Mexico were studied. From 40,957 annual hospitalizations 11,183 were due to sepsis, which represented 27.3% of admissions to ICU. From 11,183 patients with sepsis, 3402 died, representing a mortality rate of 30.4%. The most frequent sepsis trigger was abdominal infection (47%) followed by pulmonary infection (33%), soft tissue infection (8%) and kidney infection (7%); 5% were from other sources (neurological, osteoarticular). From the isolated bacteria, 52% were gram negative, 38% gram positive and 10% fungal infection; 60% of the private hospital ICUs and 40% of public hospital ICUs applied the Surviving Sepsis Campaign (p‹0.05). In 50% of each of the ICUs, they adhere to the campaign recommendations. Costs in septic patients are high. Conclusions: This study documents the high incidence of sepsis in Mexican ICUs, with high mortality rate and low adherence to Surviving Sepsis Campaign. Our data suggest that sepsis is a public health problem in Mexico.

REFERENCES

1. Brun-Buisson C, Doyon F, Carlet J. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995;274:968-974.

2. Angus DC, Linde-Zwirble WT, Lidicker J. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310.

3. Martin GS, Mannino DM, Eaton S. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554.

4. Alberti C, Brun-Buisson C, Buchardi H. Epidemiology of sepsis and infection in ICU patient from an international multicentre cohort study. Intensive Care Med 2002;28:108-121.

5. Vincent JL, Sakr Y, Sprug CL. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006;34:344-353.

6. Cheng B, Xie G, Yao S, Wu X, Guo Q, Gu M. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit Care Med 2007;35:2538-2546.

7. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-873.

8. Bone RC, Balk RA, Cerra FB. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-1655.

9. Levy MM, Fink MP, Marshall JC. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-1256.

10. Bellomo R, Ronco C, Kellum JA, Metha RL, Palevsky P. Acute renal-failure. Definition, outcome measures, animal models, fluid therapy and information technology needs. The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:204-212.

11. Miranda DR, Rijk A, Schaufeli W. Simplified Therapeutic Intervention Scoring System: The TISS-28 items: results from a multicenter study. Crit Care Med 1996;24:64-73.

12. Padkin A, Goldfrad C, Brady AR. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003;31:2332-2338.

13. Sands KE, Bates DW, Lanken PN. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997;278:234-240.

14. Finfer S, Bellomo R, Lipman J. Adult population incidence of severe sepsis in Australia and New Zealand intensive care units. Intensive Care Med 2004;30:589-596.

15. Silva E, Pedro MA, Sogaya ACB. Brazialian Sepsis Epidemiological Study (BASES study). Crit Care 2004;8:251-260.

16. Danai P, Martin GS. Epidemiology of sepsis: recent advances. Curr Infect Dis Rep 2005;7:329-334.

17. Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time. Crit Care Med 1998;26:2078-2086.

18. Cohen NH. Reduced mortality from septic shock: lessons for the future. Crit Care Med 1998;26:1956-1958.

19. Yu DT, Black E, Sands KE, Schwarts JS, Hibberd PL, Graman PS, et al. Severe sepsis: variation in resource and therapeutic modality use among academic centers. Crit Care 2003;7:24-34.

20. Tanriover MD, Guven GS, Sen D. Epidemiology and outcome of sepsis in a tertiary-care in a developing country. Epidemiol Infect 2006;134:315-322.

21. Adrie C, Alberti C, Chaix-Couturier C, Azoulay E, Lassence A. Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost. J Crit Care 2005;20:46-58.

22. Bernard GR, Vincent JL, Laterre PF, La Rosa SP, Dhainaut JF, López- Rodriguez A. Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.

23. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554.

24. Voss A, le Noble JL, Verduyn LF, Foudraine NA, Meiss JF. Candidemia in intensive care unit patients: risk factors for mortality. Infection 1997;25:8-11.

25. Vincent JL, Bihari DJ, Sufer PM, Bruining HA, White J. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 1995;274:639-644.

26. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 2002;113:480-485.

27. Levy MM, Pronovost PJ, Dellinger RP, Townsend S, Resar RK, Clemmer TP, et al. Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med 2004;32:595-597.

28. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008;34:17-60.

29. Secretaría de Salud. Diez causas de mortalidad en hombres y mujeres por grupo de edad. [Consultado el 23 de junio de 2009]. Disponible en http://sinais.salud.gob.mx/mortalidad/index.html

30. Instituto Nacional de Información Estadística y Geografía. [Consultado el 23 de junio 2009]. Disponible en http://www.inegi.org.mx/est/contenidos/espanol/proyectos/continuas/vitales/BD/tabulados/consultamortalidad.asp

31. Instituto Nacional de Información Estadística y Geografía. [Consultado el: 23 de junio 2009]. Disponible en http://www.inegi.org.mx/est/contenidos/espanol/rutinas/ept.asp?t=mpob107&c=1472

32. Kieft H, Hoepelman AI, Zhou W. The sepsis syndrome in a Dutch university hospital. Clinical observations. Arch Intern Med 1993;153:2241-2247.

33. Sundarajan V, Korman T, Visvanathan K. The microbiology and outcome of sepsis in Victoria, Australia. Epidemiol Infect 2006;134:307-314.

34. Annane D, Aegerter P, Jars-Guincestre MC, Guidetfor B. Current epidemiology of septic shock: The CUB-Rea Network. Am J Respir Crit Care Med 2003;168:165-172.

35. Salvo I, de Cian W, Musicco M, Langer M, Piadena R, Wolfler A. The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 1995;21:244-249.

36. Linde-Zwirble WT, Angus DC. Severe sepsis epidemiology: sampling, selection, and society. Crit Care 2004;8:222-226.